BioCryst Pharmaceuticals | Salgsomkostninger Og Administration

Selling And Administration Expenses Lave om Dato
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
Intra Cellular Therapies USD 104.72M 487K 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



BioCryst Pharmaceuticals Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2024.